Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-28 @ 8:14 PM
Study NCT ID:
NCT03496766
Status:
TERMINATED
Last Update Posted:
2025-03-05
First Post:
2018-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
Sponsor:
Spanish Lung Cancer Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-07
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-13
First Submit QC Date:
None
Study First Post Date:
2018-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-10-05
Results First Submit QC Date:
None
Results First Post Date:
2024-03-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-04
Last Update Post Date:
2025-03-05
Last Update Post Date Type:
ACTUAL